cephalexin

Product NDC: 42254-080
11-digit product format: 422540080
Labeler code: 42254
Product ID: 42254-080_4511cefb-084b-4191-899c-f500091f589c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: cephalexin
Dosage form: CAPSULE
Route: ORAL
Labeler: Rebel Distributors Corp
Application: ANDA062791
Marketing category: ANDA
Marketing start: 2010-06-21
Marketing end: 0000-00-00
Substance: CEPHALEXIN
Active strength: 500 mg/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 9 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	42254-080		I	Inactivated by FDA	2026-08-07
excluded package	package	42254-080	42254-080-06	I	Inactivated by FDA	2026-08-07
excluded package	package	42254-080	42254-080-12	I	Inactivated by FDA	2026-08-07
excluded package	package	42254-080	42254-080-14	I	Inactivated by FDA	2026-08-07
excluded package	package	42254-080	42254-080-20	I	Inactivated by FDA	2026-08-07
excluded package	package	42254-080	42254-080-21	I	Inactivated by FDA	2026-08-07
excluded package	package	42254-080	42254-080-28	I	Inactivated by FDA	2026-08-07
excluded package	package	42254-080	42254-080-30	I	Inactivated by FDA	2026-08-07
excluded package	package	42254-080	42254-080-40	I	Inactivated by FDA	2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 4 · 198 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42254-080-06	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42254-080-14	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42254-080-30	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42254-080-21	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42254-080-28	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42254-080-40	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42254-080-12	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42254-080-20	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42254-080-06	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42254-080-14	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42254-080-30	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42254-080-21	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42254-080-28	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42254-080-40	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42254-080-12	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42254-080-20	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42254-080-06	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42254-080-14	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42254-080-30	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42254-080-21	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42254-080-28	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42254-080-40	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42254-080-12	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42254-080-20	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42254-080-06	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42254-080-14	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42254-080-30	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42254-080-21	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42254-080-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42254-080-40	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42254-080-12	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42254-080-20	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42254-080-06	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42254-080-14	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42254-080-30	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42254-080-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42254-080-28	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42254-080-40	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42254-080-12	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42254-080-20	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42254-080-06	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42254-080-14	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42254-080-30	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42254-080-21	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42254-080-28	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42254-080-40	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42254-080-12	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42254-080-20	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42254-080-06	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42254-080-14	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42254-080-30	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42254-080-21	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42254-080-28	`302b2466d912…`	`e7b80fea0513…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A062791-001	CEPHALEXIN	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL			1987-06-11
A062791-002	CEPHALEXIN	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL			1987-06-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A062791-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	1987-06-11	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A062791-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	1987-06-11	`782e0a99824c…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-09-15 20:21 UTC	2019-09	A062791-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A062791-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A062791-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A062791-002	AB	1	`ea99ee380514…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
dfa3f520-409c-432e-b6d3-9250d468c772	Product name	1	20250401
64bb7f1a-2c2e-4741-8301-dbfeda7239f6	Product name	1	20190628
398aa563-bb78-fe0f-46a8-757c40ef28bf	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
42254-080-06	Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
42254-080-12	Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
42254-080-14	Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
42254-080-20	Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
42254-080-21	Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
42254-080-28	Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
42254-080-30	Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
42254-080-40	Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
42254-080-06	cephalexin	6 in 1 BOTTLE	CAPSULE	6	2
42254-080-12	cephalexin	12 in 1 BOTTLE	CAPSULE	12	2
42254-080-14	cephalexin	14 in 1 BOTTLE	CAPSULE	14	2
42254-080-20	cephalexin	20 in 1 BOTTLE	CAPSULE	20	2
42254-080-21	cephalexin	21 in 1 BOTTLE	CAPSULE	21	2
42254-080-28	cephalexin	28 in 1 BOTTLE	CAPSULE	28	2
42254-080-30	cephalexin	30 in 1 BOTTLE	CAPSULE	30	2
42254-080-40	cephalexin	40 in 1 BOTTLE	CAPSULE	40	2

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
42254-080-06	EA - Each	42254-080	f9c78d29-7c44-4779-893e-022e86d1cb04	1	2012-07-24
42254-080-12	EA - Each	42254-080	7b1283de-d965-4e5a-9f02-a08944bc32a1	1	2012-07-24
42254-080-14	EA - Each	42254-080	384c157e-ebf7-4b27-9786-72671da80dad	1	2013-04-01
42254-080-20	EA - Each	42254-080	a5168a9c-50f0-4ea4-8f9a-1a250c03f040	1	2012-07-24
42254-080-21	EA - Each	42254-080	c80a2d91-a1b0-4a6e-8d7f-9a2ec34aaba0	1	2013-04-01
42254-080-28	EA - Each	42254-080	d0f98feb-8d98-4e05-9e68-aebd48fe8937	1	2012-07-24
42254-080-30	EA - Each	42254-080	efa85219-04b0-4956-9a47-075de8ea6e98	1	2012-07-24
42254-080-40	EA - Each	42254-080	d143188e-b321-42a1-a781-94ad6cfae524	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEPHALEXIN	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP]	2
CEPHALEXIN ANHYDROUS	ACTIVE MOIETY	5SFF1W6677	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP]	2
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP]	2
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP]	2
FD&C GREEN NO. 3	INACTIVE INGREDIENT	3P3ONR6O1S	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP]	2
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP]	2
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP]	2
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
42254-080	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP]	2	Legacy NDC, 8 package rows	20130329_c5604b48-d58f-45ac-8602-72241ed4b906.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
OBN7UDS42Y	CEPHALEXIN	23325-78-2	CEPHALEXIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
309114	cephalexin 500 MG Oral Capsule	PSN	c5604b48-d58f-45ac-8602-72241ed4b906	2
309114	cephalexin 500 MG Oral Capsule	SCD	c5604b48-d58f-45ac-8602-72241ed4b906	2
309114	cefalexin (as cefalexin monohydrate) 500 MG Oral Capsule	SY	c5604b48-d58f-45ac-8602-72241ed4b906	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
42254-080-06	42254008006	6 in 1 BOTTLE	Historical
42254-080-12	42254008012	12 in 1 BOTTLE	Historical
42254-080-14	42254008014	14 in 1 BOTTLE	Historical
42254-080-20	42254008020	20 in 1 BOTTLE	Historical
42254-080-21	42254008021	21 in 1 BOTTLE	Historical
42254-080-28	42254008028	28 in 1 BOTTLE	Historical
42254-080-30	42254008030	30 in 1 BOTTLE	Historical
42254-080-40	42254008040	40 in 1 BOTTLE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
cephalexin	Rebel Distributors Corp \| PSS World Medical, Inc. \| STAT RX USA LLC \| Dispensing Solutions, Inc. \| SCRIPT PAK \| Keltman Pharmaceuticals, Inc. \| Rebel Distirbutors Corp.	2011-12-27	HUMAN PRESCRIPTION DRUG LABEL	2